• Thumbnail for Semaglutide
    Semaglutide is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management...
    66 KB (5,432 words) - 03:10, 31 August 2024
  • Cagrilintide/semaglutide, marketed as CagriSema, is a combination of cagrilintide, a dual amylin and calcitonin receptor agonist, and semaglutide, a GLP-1...
    6 KB (422 words) - 13:41, 6 August 2024
  • Insulin icodec/semaglutide, or IcoSema, is a combination medication of insulin icodec and semaglutide in development for type 2 diabetes by Novo Nordisk...
    3 KB (97 words) - 12:15, 28 March 2024
  • on Paramount+. The special satirizes celebrities' glamorized usage of semaglutide-based weight loss drugs and Big Sugar, as well as Lizzo and the inaccessibility...
    13 KB (1,367 words) - 10:40, 28 August 2024
  • one weight-related comorbidity. Although some GLP-1 agonists such as semaglutide are more effective than other weight loss drugs, they are still less...
    37 KB (3,890 words) - 03:08, 12 August 2024
  • and type 2 diabetes by itself and in combination with semaglutide as cagrilintide/semaglutide. Larsen, Anna T.; Sonne, Nina; Mohamed, Khaled Elhady;...
    10 KB (415 words) - 13:40, 6 August 2024
  • Thumbnail for Tirzepatide
    the second GLP-1 drug to show positive results in this area, following semaglutide, to date. Tirzepatide is contraindicated for use in people with a personal...
    44 KB (3,528 words) - 18:08, 3 September 2024
  • Thumbnail for Glucagon-like peptide-1 receptor
    beinaglutide dulaglutide efpeglenatide langlenatide liraglutide PEG- Loxenatide semaglutide taspoglutide Ecnoglutide Utreglutide Glepaglutide Apraglutide Maridebart...
    33 KB (4,071 words) - 15:36, 30 July 2024
  • Thumbnail for Anti-obesity medication
    weight loss. The medications liraglutide, naltrexone/bupropion, orlistat, semaglutide, and tirzepatide are approved by the US Food and Drug Administration...
    53 KB (4,991 words) - 05:08, 21 July 2024
  • and university professor. She led the development of liraglutide and semaglutide,[third-party source needed] two notable drugs approved for indications...
    15 KB (1,637 words) - 22:56, 4 July 2024